Jake Holdreith Shortlisted by LMG Life Sciences for Hatch-Waxman Litigator of the Year

August 2, 2021

Robins Kaplan LLP is pleased to announce that Jake Holdreith has been named to LMG Life Sciences 2021 shortlist for Hatch-Waxman Litigator of the Year – Generic. Only five attorneys in the country were recognized on this list.

Holdreith is a member of the firm’s executive board. He has tried jury cases to multi-million dollar verdicts and resolved complex cases at all stages of litigation. He is a skilled and creative strategist and business counselor who can cut to the heart of a matter in the boardroom and the courtroom. Holdreith counsels clients and tries complex lawsuits in a range of practice areas. He is known for work in in the pharmaceutical, chemical, and electronics industries and has handled cases in the United States, Europe, and Asia.

Holdreith has previously been recognized by LMG Life Sciences as a “Life Sciences Star” and as “General Patent Litigator of the Year.” He was also the recipient of the “Hatch Waxman Impact Cases of the Year” award in 2016.

You can find a complete list of the nominees here. The winner of this year’s award will be announced at a ceremony in New York City on September 22, 2021.

Jake M. Holdreith

Partner

Managing Partner, Minneapolis Office
Member of Executive Board

Related Publications

November 8, 2024
Trademark tensions on the track: Court upholds First Amendment protections in Haas v. Steiner
David Martinez, Navin Ramalingam - Los Angeles & San Francisco Daily Journal
September 18, 2024
Astellas Pharma, Inc. v. Sandoz Inc.
GENERICally Speaking Hatch Waxman Bulletin
September 9, 2024
Purdue Pharma L.P v. Accord Healthcare Inc.
GENERICally Speaking Hatch Waxman Bulletin
September 4, 2024
Exeltis USA, Inc. v. Lupin Ltd.
GENERICally Speaking Hatch Waxman Bulletin
August 28, 2024
Teva Branded Pharm. Products R&D, Inc. v. Deva Holding A.S.
GENERICally Speaking Hatch Waxman Bulletin
Back to Top